Glomerular disease: Membranous nephropathy and the Henle–Koch postulates
暂无分享，去创建一个
[1] K. Budde,et al. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy. , 2016, The Journal of clinical investigation.
[2] P. Stahl,et al. A Mechanism for Cancer-Associated Membranous Nephropathy. , 2016, The New England journal of medicine.
[3] H. Debiec,et al. Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients. , 2015, Molecular immunology.
[4] C. Porta,et al. Glomerular diseases and cancer: evaluation of underlying malignancy , 2015, Journal of Nephrology.
[5] H. Debiec,et al. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care , 2015, The Lancet.
[6] J. Klein,et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. , 2015, The New England journal of medicine.
[7] U. Panzer,et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.
[8] David M. Beck,et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.
[9] J. Haymann,et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. , 2002, The New England journal of medicine.